Patents Assigned to 501 Societe Civile de Recherches et d'Etudes Theraputiques
  • Medicaments based on zinc gluconate useful for the treatment of hyperprolactinaemias
    Patent number: 4618601
    Abstract: This invention relates to the use of zinc gluconate for making a medicament administered by the oral route and containing from 50 to 150 mg of zinc gluconate, said medicament being used for the treatment of hyperprolactinaemias.
    Type: Grant
    Filed: December 3, 1985
    Date of Patent: October 21, 1986
    Assignee: 501 Societe Civile de Recherches et d'Etudes Theraputiques
    Inventors: Guy Chazot, Catherine Suck